Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis
Not Applicable
Completed
- Conditions
- RhinosinusitisRhinitis
- Interventions
- Combination Product: Bacillus subtilis DSM32444Drug: Neomycin/ Dexameythasone/Xylometazoline
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Huro Biotech Joint Stock Company
- Target Recruit Count
- 60
- Registration Number
- NCT05999955
- Locations
- 🇻🇳
Thai Binh University of Medicine and Pharmacy, Thái Bình, Thai Binh, Vietnam
Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans
Not Applicable
Completed
- Conditions
- Rhino Sinusitis
- Interventions
- Drug: 0.9% NaCl isotonic saline solutionCombination Product: Bacillus subtilis DSM32444, inactivated
- First Posted Date
- 2023-08-09
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Huro Biotech Joint Stock Company
- Target Recruit Count
- 60
- Registration Number
- NCT05984004
- Locations
- 🇻🇳
Thai Binh University of Medicine and Pharmacy, Thái Bình, Thai Binh, Vietnam
© Copyright 2025. All Rights Reserved by MedPath